Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Generex Biotechnology Corp

+ Add to Watchlist

GB8:GR

0.023 EUR 0.002 9.52%

As of 13:36:54 ET on 04/27/2015.

Snapshot for Generex Biotechnology Corp (GB8)

Open: 0.020 Day's Range: 0.020 - 0.026 Volume: 10,100
Previous Close: 0.021 52wk Range: 0.008 - 0.032 1-Yr Rtn: -14.81%

Stock Chart for GB8

No chart data available.
  • GB8:GR 0.023
  • 1D
  • 1M
  • 1Y
0.021
Interactive GB8 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GB8

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 18.21
Shares Outstanding (M) 791.54
30 Day Average Volume 71,326
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GB8

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GB8

Generex Biotechnology Corporation researches and develops drug delivery systems and technology. The Company's initial product is an insulin formulation that is administered as a fine spray into the oral cavity using a hand held aerosol applicator. Generex is conducting clinical trials of its product in the United States, Canada, England, and Italy.

Mark A FletcherPresident/Exec VP/CEOStephen FellowsChief Financial Officer
David A BrusegardCOO/SecretaryEric Von HofeVice President
More Company Profile & Key Executives for GB8

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil